Skip to content

Superior Application and Role of His-Bundle Pacing Study

Superior Application and Role of His-Bundle Pacing Study - SAPPORO-HBP Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000033720
Enrollment
20
Registered
2018-08-15
Start date
2018-08-15
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bradycardia

Interventions

None listed

Sponsors

Sapporo City General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Among patients referred to Sapporo City General Hospital for permanent pacemaker implantation due to bradycardia, those with a LVEF less than 50% and either PR prolongation (200 ms and more) or QRS prolongation (100 ms and more) are eligible.

Exclusion criteria

Exclusion criteria: Patients with an indication for cardiac resynchronization therapy are excluded.

Design outcomes

Primary

MeasureTime frame
Changes in maximum rate of left ventricular pressure (LV-dP/dtmax) by His bundle pacing

Secondary

MeasureTime frame
Secondary outcomes were all-cause death, heart failure hospitalization and upgrade to biventricular pacing system.

Countries

Japan

Contacts

Public ContactMasahiro Toba

Sapporo City General Hospital Cardiovascular Medicine

masahiro-toba@doc.city.sapporo.jp011-726-2211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026